107 related articles for article (PubMed ID: 31794072)
1. Pharmacodynamic and pharmacokinetic profile of SM-1, a triple-drug combination to increase total sleep time.
Dahl T; Chen LB; Scheinin M; Suopanki-Lalowski J; Valge M; Puhakka A; Mikola H; Lovró Z; Meierjohann A; Vuorilehto L; Roth T
Hum Psychopharmacol; 2019 Nov; 34(6):e2716. PubMed ID: 31794072
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of SM-1 in a transient insomnia model.
Dahl T; Chen LB; Zammit G; Ahmad M; Roth T
Hum Psychopharmacol; 2019 Nov; 34(6):e2713. PubMed ID: 31837050
[TBL] [Abstract][Full Text] [Related]
3. Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
Saletu B; Saletu-Zyhlarz G; Anderer P; Brandstätter N; Frey R; Gruber G; Klösch G; Mandl M; Grünberger J; Linzmayer L
Neuropsychobiology; 1997; 36(3):130-52. PubMed ID: 9313245
[TBL] [Abstract][Full Text] [Related]
4. Effects of suvorexant, an orexin receptor antagonist, on sleep parameters as measured by polysomnography in healthy men.
Sun H; Kennedy WP; Wilbraham D; Lewis N; Calder N; Li X; Ma J; Yee KL; Ermlich S; Mangin E; Lines C; Rosen L; Chodakewitz J; Murphy GM
Sleep; 2013 Feb; 36(2):259-67. PubMed ID: 23372274
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamic effects of suvorexant and zolpidem on EEG during sleep in healthy subjects.
Struyk A; Gargano C; Drexel M; Stoch SA; Svetnik V; Ma J; Mayleben D
Eur Neuropsychopharmacol; 2016 Oct; 26(10):1649-56. PubMed ID: 27554636
[TBL] [Abstract][Full Text] [Related]
6. Effects of zolpidem and zaleplon on cognitive performance after emergent morning awakenings at Tmax: a randomized placebo-controlled trial.
Dinges DF; Basner M; Ecker AJ; Baskin P; Johnston SL
Sleep; 2019 Mar; 42(3):. PubMed ID: 30576525
[TBL] [Abstract][Full Text] [Related]
7. Sleep and residual sedation after administration of zaleplon, zolpidem, and placebo during experimental middle-of-the-night awakening.
Zammit GK; Corser B; Doghramji K; Fry JM; James S; Krystal A; Mangano RM
J Clin Sleep Med; 2006 Oct; 2(4):417-23. PubMed ID: 17557470
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic and pharmacodynamic interactions between zolpidem and caffeine.
Cysneiros RM; Farkas D; Harmatz JS; von Moltke LL; Greenblatt DJ
Clin Pharmacol Ther; 2007 Jul; 82(1):54-62. PubMed ID: 17443132
[TBL] [Abstract][Full Text] [Related]
9. Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo.
Greenblatt DJ; Harmatz JS; von Moltke LL; Ehrenberg BL; Harrel L; Corbett K; Counihan M; Graf JA; Darwish M; Mertzanis P; Martin PT; Cevallos WH; Shader RI
Clin Pharmacol Ther; 1998 Nov; 64(5):553-61. PubMed ID: 9834048
[TBL] [Abstract][Full Text] [Related]
10. Sedation and memory: studies with a histamine H-1 receptor antagonist.
Turner C; Handford AD; Nicholson AN
J Psychopharmacol; 2006 Jul; 20(4):506-17. PubMed ID: 16401664
[TBL] [Abstract][Full Text] [Related]
11. Daytime pharmacodynamic and pharmacokinetic evaluation of low-dose sublingual transmucosal zolpidem hemitartrate.
Roth T; Mayleben D; Corser BC; Singh NN
Hum Psychopharmacol; 2008 Jan; 23(1):13-20. PubMed ID: 17907263
[TBL] [Abstract][Full Text] [Related]
12. EEG profile of intravenous zolpidem in healthy volunteers.
Patat A; Trocherie S; Thebault JJ; Rosenzweig P; Dubruc C; Bianchetti G; Court LA; Morselli PL
Psychopharmacology (Berl); 1994 Feb; 114(1):138-46. PubMed ID: 7846196
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
Roth T; Soubrane C; Titeux L; Walsh JK;
Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
[TBL] [Abstract][Full Text] [Related]
14. Effects on postural oscillation and memory functions of a single dose of zolpidem 5 mg, zopiclone 3.75 mg and lormetazepam 1 mg in elderly healthy subjects. A randomized, cross-over, double-blind study versus placebo.
Allain H; Bentué-Ferrer D; Tarral A; Gandon JM
Eur J Clin Pharmacol; 2003 Jul; 59(3):179-88. PubMed ID: 12756510
[TBL] [Abstract][Full Text] [Related]
15. Effect of CYP3A4 metabolism on sex differences in the pharmacokinetics and pharmacodynamics of zolpidem.
Yoon S; Jeong S; Jung E; Kim KS; Jeon I; Lee Y; Cho JY; Oh WY; Chung JY
Sci Rep; 2021 Sep; 11(1):19150. PubMed ID: 34580385
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Mirogabalin When Coadministered With Lorazepam, Zolpidem, Tramadol, or Ethanol: Results From Drug-Drug Interaction Studies in Healthy Subjects.
Jansen M; Mendell J; Currie A; Dow J; He L; Merante D; Dishy V; Ishizuka H; Zahir H
Clin Pharmacol Drug Dev; 2018 Aug; 7(6):597-612. PubMed ID: 29870596
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the Abuse Potential of the Orexin Receptor Antagonist, Suvorexant, Compared With Zolpidem in a Randomized Crossover Study.
Schoedel KA; Sun H; Sellers EM; Faulknor J; Levy-Cooperman N; Li X; Kennedy WP; Cha JH; Lewis NM; Liu W; Bondiskey P; McCrea JB; Panebianco DL; Troyer MD; Wagner JA
J Clin Psychopharmacol; 2016 Aug; 36(4):314-23. PubMed ID: 27253658
[TBL] [Abstract][Full Text] [Related]
18. Randomised clinical trial of the effects of prolonged-release melatonin, temazepam and zolpidem on slow-wave activity during sleep in healthy people.
Arbon EL; Knurowska M; Dijk DJ
J Psychopharmacol; 2015 Jul; 29(7):764-76. PubMed ID: 25922426
[TBL] [Abstract][Full Text] [Related]
19. [Contribution of zolpidem in the management of sleep disorders].
Lavoisy J; Zivkovic B; Benavides J; Perrault GH; Robert P
Encephale; 1992; 18(4):379-92. PubMed ID: 1363657
[TBL] [Abstract][Full Text] [Related]
20. A translational, caffeine-induced model of onset insomnia in rats and healthy volunteers.
Paterson LM; Wilson SJ; Nutt DJ; Hutson PH; Ivarsson M
Psychopharmacology (Berl); 2007 May; 191(4):943-50. PubMed ID: 17225163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
